title: Cytidine Deaminase Activity Assessment to Select Perioperative Chemotherapy Regimen in Localized Bladder Cancer.
authors.affiliation: Department of Medical Oncology, Hopital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France.
authors.forename: Clemence
authors.initials: C
authors.lastname: Henon
authors.affiliation: Department of Medical Oncology, Hopital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France. Electronic address: olivier.huillard@aphp.fr.
authors.forename: Olivier
authors.initials: O
authors.lastname: Huillard
authors.affiliation: UF Pharmacocinétique et Pharmacochimie, Hopital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France.
authors.forename: Laure-Hélène
authors.initials: LH
authors.lastname: Preta
authors.affiliation: UF Pharmacocinétique et Pharmacochimie, Hopital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France.
authors.forename: Benoit
authors.initials: B
authors.lastname: Blanchet
authors.affiliation: Department of Medical Oncology, Hopital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France.
authors.forename: Francois
authors.initials: F
authors.lastname: Goldwasser
authors.affiliation: Department of Medical Oncology, Hopital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France.
authors.forename: Jerome
authors.initials: J
authors.lastname: Alexandre
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D014408:Biomarkers, Tumor / Q000032:analysis; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects / Q000379:methods; D003564:Cytidine Deaminase / Q000097:blood*; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism; D006801:Humans; D008297:Male; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*; D000093542:Gemcitabine
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D003841:Deoxycytidine; D003564:Cytidine Deaminase; D000093542:Gemcitabine
keywords: Adjuvant chemotherapy; Drug metabolism; Gemcitabine; Neoadjuvant chemotherapy; Urothelial carcinoma